Clin2
NCT07682402Possibly a fitNot yet recruiting

Taurine for teens with lingering COVID symptoms

Long COVIDPost COVID-19 ConditionPASC Post Acute Sequelae of COVID 19

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This study tests whether taking a daily supplement called taurine helps teenagers who still have COVID symptoms like fatigue or brain fog months after their infection. It may offer a simple way to feel better.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
30 people
Ages
10 years to 17 years
Study type
Interventional

Who can take part

  • You are between 10 and 17 years old.
  • You had COVID-19 at least 3 months ago, and your symptoms have lasted for at least 2 months.
  • You still have symptoms like tiredness or trouble thinking right now.
  • You are not taking any prescription medications for fatigue or memory problems (or you can stop them 4 weeks before the study starts).
  • You agree not to take extra taurine (like from energy drinks or supplements) during the study.
  • If you are sexually active and could get pregnant, you must agree to use birth control or not have sex.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06721949Recruiting· Phase 2/Phase 3
Taurine for long COVID symptoms

This trial tests if taking taurine, a natural amino acid supplement, can help reduce lingering symptoms of COVID-19 that last for months. If you have had COVID-19 and still have symptoms like fatigue or brain fog for at least 2 months after 3 months from your infection, this study might be for you.

Edmonton, Alberta
NCT07278388Recruiting
Fatigue and brain fog in long COVID: a brain study

This trial uses brain scans to understand why people with long COVID feel very tired or have trouble thinking clearly. It could help find new treatments for these symptoms.

Baltimore, Maryland
NCT07597902Not yet recruiting· Phase 2
Antiviral treatment for long covid symptoms

This study tests whether a combination of antiviral medications can help reduce Long COVID symptoms by targeting viruses that may stay in the body. If you have Long COVID, this treatment might help you feel better.

New York, New York
NCT07076862Recruiting· Early Phase 1
PET scan study for long COVID symptoms

This study uses a special PET scan to look at inflammation in the body of people with long COVID (symptoms lasting 3+ months after infection). The goal is to understand why symptoms persist and find better ways to help.

Sacramento, California
NCT06928272Recruiting· Phase 3
Long COVID drug study for adults 18 to 65

This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.

San Diego, California
NCT06577467Recruiting
Studying leftover virus after covid recovery

This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.

Bethesda, Maryland

Hear when a new Long COVID trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.